List of works by Robert Spiera

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis

scientific article published on 30 January 2017

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis

scientific article published on 30 January 2017

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

scientific article

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

scientific article published on 31 October 2020

Arterial lesions in giant cell arteritis: A longitudinal study

scientific article published on 09 May 2018

Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis

scientific article (publication date: 2012)

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis

scientific article published on December 2011

Efficacy of remission-induction regimens for ANCA-associated vasculitis

scientific article

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

scientific article published on 28 December 2016

Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

scientific article published on July 2015

Response to Mittal and Sharma Letter to the Editor

scientific article published on 08 November 2020

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

scientific article published on 24 June 2020

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

scientific article

Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement

scientific article

Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with systemic sclerosis

scientific article published on 26 April 2020